Veracyte, Inc. (NASDAQ:VCYT) Q4 2023 Earnings Call Transcrip

Veracyte, Inc. misses on earnings expectations. Reported EPS is $-0.39 EPS, expectations were $-0.07. Veracyte, Inc.

Related Keywords

United States , France , Turkey , Turk , William Blair , Marc Stapley , Shayla Gorman , Dustin Scaringe , Ji Nam , Mason Carrico , Rebecca Chambers , Morgan Stanley , Exchange Commission , Research Use , Society Of Urologic Oncology , Scotiabank , National Comprehensive Cancer Network , Veracyte Inc , Nasdaq , Call Transcript February , Veracyte Fourth Quarter , Full Year , Senior Director , Investor Relations , Chief Executive Officer , Chief Financial , Decipher Prostate , Research Use Only , Urologic Oncology , Veracyte Diagnostics Platform , Global Expansion , Solving New Cancer Challenges , Percepta Nasal Swab , Marseille France , Exercises For Lower Back Pain , Dog Breeds For First Time , Sung Ji Nam , Yes Sung , Tejas Savant , Unidentified Analyst ,